Crsp stock forecast 2025.

Jun 6, 2021 · For Editas Medicine stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Editas Medicine stock forecast of $8.2, a high forecast of $8.21, and a low forecast of $8.19. The average Editas Medicine stock forecast 2031 represents a 4.21% increase from the last price of $7.86999988555908.

Crsp stock forecast 2025. Things To Know About Crsp stock forecast 2025.

Nov 30, 2023 · Teladoc Health Stock Forecast 12-04-2023. Forecast target price for 12-04-2023: $ 18.40. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.308%. Pessimistic target level: 18.09. Optimistic target level: 18.52. Oct 27, 2023 · Analyzing the anticipated performance of CRISPR Therapeutics, the ceiling value that the stock is expected to reach in 2025 stands at a promising $75.1.Indicating a bullish trend, an upside potential of 67.9% signals profitable prospects, with an average monthly return of 2.61%, beckoning investors to consider amplifying their portfolios. Find the latest CRISPR Therapeutics AG CRSP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. Forecast target price for 10-29-2023: $41.07. Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 2.788%. Pessimistic ...The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 33.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...

Jul 6, 2023 · The stock is covered by 27 analysts and has a consensus price target of $83.78 which would be a 48% gain from the stock’s price as of this writing. Vertex Pharmaceuticals (VRTX) Source: Pavel ...

Explore CRSP’s stock database and find out why it is relied on by researchers across the globe. More . CRSP Coverage. Learn about the breadth of coverage for CRSP data in this video overview. ... Take a guided tour through I/B/E/S data — the premier analyst forecast data in academia. More .Get a real-time CRISPR Therapeutics AG (CRSP) stock price quote with breaking news, financials, statistics, charts and more.

Nov 30, 2023 · Based on short-term price targets offered by 22 analysts, the average price target for CRISPR Therapeutics AG comes to $89.77. The forecasts range from a low of $42.00 to a high of $220.00. The ... MarketsandMarkets puts the estimate at $11.2 billion by 2025 while Emergen Research estimates the global market size to be $15.79 billion by 2027 or around 17% compounded annual growth rate.Jan 13 Show all updates Earnings and Revenue Growth Forecasts Show more Analyst Future Growth Forecasts Earnings vs Savings Rate: CRSP is forecast to remain unprofitable over the next 3 years. Earnings vs Market: CRSP is forecast to remain unprofitable over the next 3 years.22 thg 12, 2022 ... The news had a broad impact on gene-editing stocks including CRSP stock, which fell almost 3%. ... CRISPR Therapeutics Shows Rising Price ...

Find real-time ABNB - Airbnb Inc stock quotes, company profile, news and forecasts from CNN Business.

About the Roku, Inc. stock forecast. As of 2023 November 30, Thursday current price of ROKU stock is 106.720$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Roku Inc - Class A stock price as been showing a rising tendency so we believe that similar market segments …

CRISPR Stock (CRSP) Forecast and Prediction for 2025 In the groundbreaking realm of biotech, few names resonate as strongly as CRISPR Therapeutics. Born out of the …CRISPR Therapeutics last issued its quarterly earnings data on November 6th, 2023. The reported ($1.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.04) by $0.63. CRISPR Therapeutics has generated ($4.47) earnings per share over the last year ( ($4.47) diluted earnings per share).32.69%. Dividend Yield. N/A. More importantly, CRISPR Therapeutics' financial results should improve in the next five years. The company is on the verge of receiving approval for exa-cel, a gene ...Target values for the price of one Luminar Technologies share for Mar 2025. The weighted average target price per Luminar Technologies share in Mar 2025 is: 2.61. In Mar, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.345% volatility is expected. Pessimistic target level: 2.42.Jul 6, 2023 · The stock is covered by 27 analysts and has a consensus price target of $83.78 which would be a 48% gain from the stock’s price as of this writing. Vertex Pharmaceuticals (VRTX) Source: Pavel ...

Did I mention that clinical-stage biotech stocks are a great source of jaw-dropping growth over the next decade? CRISPR Therapeutics (CRSP-6.39%), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from … See moreCRSP: Keep it Crisp for 2025. dsypher Aug 15. A little idea for CRSP ... stock drop below $ 57.80 then Sell ITM Put for $ 75 and collect high premium. 3.It is projected to grow at a compounded annual growth rate of 8% to be valued at $14 billion by 2030. Under the terms of the deal, Vertex paid CRISPR $100 million up front for those rights and ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Salesforce share forecasts, stock quote and buy / sell signals below. According to present data Salesforce's CRM shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).The average price target for CrowdStrike Holdings is $203.15. This is based on 34 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $240.00 ,the lowest forecast is $167.00. The average price target represents -2.79% Decrease from the current price of $208.98.According to our current TSLA stock forecast, the value of Tesla shares will drop by -7.59% and reach $ 220.53 per share by December 6, 2023. According to our technical indicators, the current sentiment is Neutral while the Fear & Greed Index is showing 39 (Fear).TSLA stock recorded 15/30 (50%) green days with 5.95% price volatility over the last 30 days.

Next reporting date. February 22, 2024. EPS forecast (this quarter) -$1.43. Annual revenue (last year) $52.1M. Annual profit (last year) -$474.2M. Net profit margin.Amazon Stock Forecast 12-07-2023. Forecast target price for 12-07-2023: $ 150.20. Positive dynamics for Amazon shares will prevail with possible volatility of 1.272%. Pessimistic target level: 149.24. Optimistic target level: 151.16.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Teladoc Health share forecasts, stock quote and buy / sell signals below. According to present data Teladoc Health's TDOC shares and potentially its market environment have been in bearish cycle last 12 months (if exists).We feed our Machine Learning (AI based) forecast algorithm data from the most influential global exchanges. There are a number of existing AI-based platforms that try to predict the future of Stock markets. They include data research on historical volume, price movements, latest trends and compare it with the real-time performance of the market.The weighted average target price per CRISPR Therapeutics share in Dec 2023 is: 68.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.330% volatility is expected. CRISPR Therapeutics stock price predictions for 2023 using artificial intelligence.See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Adobe Inc. (NASDAQ:ADBE) announced its quarterly earnings data on Thursday, September, 14th. The software company reported $4.09 EPS for the quarter, topping the consensus estimate of $3.98 by $0.11. The software company had revenue of $4.89 billion for the quarter, compared to analysts' expectations of $4.87 billion.CRISPR Therapeutics AG Stock Prediction 2025. The CRISPR Therapeutics AG stock prediction for 2025 is currently $ 114.05, assuming that CRISPR Therapeutics AG shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 70.91% increase in the CRSP stock price.Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 23.00, with a high estimate of 30.00 and a low estimate of 13.00. The ...Palantir Technologies Inc - Class A (PLTR) stock price prediction is 15.953138725275 USD. The Palantir Technologies Inc - Class A stock forecast is 15.953138725275 USD for 2024 December 01, Sunday with technical analysis.About the Alphabet, Inc. stock forecast. As of 2023 December 02, Saturday current price of GOOGL stock is 132.450$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Alphabet Inc Class A stock price as been showing a rising tendency so we believe that similar market segments …CRISPR Therapeutics Stock Forecast 30 Nov. Presumably, on 11/30/2023, the price of shares will be in the range of $51.94 - $53.92. A $1.98 range width can provide 3.81% volatility. The weighted average price of this range is at $53.49, which is $0.93 higher than the previous day's weighted average price.

CRISPR Therapeutics AG Stock Forecast, CRSP stock price prediction. Price target in 14 days: 83.094 USD. ... CRISPR Therapeutics AG Stock Price Forecast for 2025 ...

Find real-time MU - Micron Technology Inc stock quotes, company profile, news and forecasts from CNN Business.

See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Price Prediction CRISPR Therapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.Bought 677,957 shares — estimated to be worth $65.6 million — in Crispr Therapeutics AG (NASDAQ:CRSP) on the dip. Shares of the company closed 5.67% lower at $96.77 on Wednesday.Meta Platforms Inc. () Stock Market info Recommendations: Buy or sell Meta Platforms stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Meta Platforms share forecasts, stock quote and buy / sell signals below.According to present data Meta Platforms's META shares and potentially its market environment have …InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are plenty of electric vehicle (EV) startups out there to choose from. So... InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are plenty of electri...Forecast target price for 10-29-2023: $41.07. Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 2.788%. Pessimistic ...Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Corsair Gaming Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 14.00. The median ...A new market forecast predicts app spending will reach $270 billion by the year 2025, including paid downloads, in-app purchases and subscriptions. According to data from Sensor Tower, in-app spending will return to pre-pandemic levels of s...Target values for the price of one Clover Health Investments share for Nov 2025. The weighted average target price per Clover Health Investments share in Nov 2025 is: 2.33. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 22.238% volatility is expected. Pessimistic target level: 2.00.About the Roku, Inc. stock forecast. As of 2023 November 30, Thursday current price of ROKU stock is 106.720$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Roku Inc - Class A stock price as been showing a rising tendency so we believe that similar market segments …Find real-time MU - Micron Technology Inc stock quotes, company profile, news and forecasts from CNN Business.

Traders Union experts conducted a comprehensive analysis and predicted that by the end of 2024 Google price will hit $179.92. Google will grow to $200.9 in 2025, $279.67 in 2028 and $348.68 in 2030. Traders Union analysts have prepared a selection of analytical forecasts from top portals for 2024, 2025, 2030.Find real-time VTRS - Viatris Inc stock quotes, company profile, news and forecasts from CNN Business.Find real-time CRSR - Corsair Gaming Inc stock quotes, company profile, news and forecasts from CNN Business.Instagram:https://instagram. 3month treasuryhitek filmsstocks that pay highest dividendsamerican bond fund Dec 1, 2023 · According to 16 stock analysts, the average 12-month stock price forecast for CRSP stock stock is $69.88, which predicts an increase of 1.79%. The lowest target is $42 and the highest is $110. On average, analysts rate CRSP stock stock as a buy. Analyst Consensus: Buy Analyst Ratings Mar 9, 2021 · CRISPR Therapeutics AG Stock Prediction 2025. The CRISPR Therapeutics AG stock prediction for 2025 is currently $ 114.05, assuming that CRISPR Therapeutics AG shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 70.91% increase in the CRSP stock price. plya stock pricebest brokers for etfs Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Corsair Gaming Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 14.00. The median ...See the latest CRISPR Therapeutics AG stock price (CRSP:XNAS), related news, valuation, dividends and more to help you make your investing decisions. lead pennies 1943 value By 2025, Amazon’s stock price should reach $5,000, and by 2028 it will most likely hit about $10,000, give or take 20%.”. — Jana Kane, LiteForex. AMZN stock was down 7.1% as of Friday ...CRSP : CRISPR Therapeutics AG stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue …Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.